Abstract
The artificial pancreas is an imprecise term that can mean a bioengineered product, such as an islet cell transplant, gene therapy to replace the pancreas, or the combination of a continuous glucose sensor, an insulin pump (with or without a glucagon pump), and a computer with an algorithm to control the delivery of insulin. In this chapter, we will consider only the last. This is an exciting topic with products being developed by an unusual consortium of academics, the JDRF, the NIH, the FDA, the Helmsley Foundation, and medical device companies. The first artificial pancreas was approved by the FDA in October of 2016 and was first marketed in June 2017 [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Weinzimer SA. Closed-loop systems: diversity and natural selection. Diabetes Care. 2012;35(11):2111–2.
Kadish AH. Automation control of blood sugar. I. A servomechanism for glucose monitoring and control. Am J Med Electron. 1964;3:82–6.
Cobelli C, Renard E, Kovatchev B. Artificial pancreas: past, present, future. Diabetes. 2011;60(11):2672–82.
Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W. An artificial endocrine pancreas. Diabetes. 1974;23:389–96.
Doyle FJ III, Huyett LM, Lee JB, Zisser HC, Dassau E. Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care. 2014;37(5):1191–7.
Lunze K, Singh T, Walter M, Brendel M, Leonhardt S. Blood glucose control algorithms for type 1 diabetic patients: a methodological review. Biomed Signal Process Control. https://doi.org/10.2016/j.bspc.2012.9.003. Accessed 12/30/2016.
Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R, Band MM, Reekie G, Leese P. Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med. 2005;22:749–55.
FDA. The Content of Investigational Device Exemption (IDE) and Premarket Approval (PMA) Applications for Artificial Pancreas Device Systems. 2012.
Yuan S, Fernando A, Klonoff DC. Standards for Medical Device Cybersecurity in 2018. https://doi.org/10.1177/1932296818763634. Accessed 25 April 2019.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Glossary
- AP
-
Artificial pancreas
- CGMS
-
Continuous glucose monitoring system
- FDA
-
US Food and Drug Administration
- HbA1c
-
Hemoglobin A11c
- iOS
-
Apple operating system
- MPC
-
Model predictive control. A controller algorithm
- PID
-
Proportional integral derivative. A controller algorithm
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ginsberg, B.H., Mauseth, R. (2019). The Artificial Pancreas. In: Rodriguez-Saldana, J. (eds) The Diabetes Textbook. Springer, Cham. https://doi.org/10.1007/978-3-030-11815-0_63
Download citation
DOI: https://doi.org/10.1007/978-3-030-11815-0_63
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11814-3
Online ISBN: 978-3-030-11815-0
eBook Packages: MedicineMedicine (R0)